fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Phenytoin (diphenylhydantoin)

Form:

4 of 4 products shown

All products: general benefit

Taro-Phenytoin · DIN 02250896 · 25 mg/mL · oral liquid

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Taro-Phenytoin · DIN 02250896 Manufacturer: Taro Pharmaceuticals Inc.; listing date 2005-11-08 Health Canada: Marketed since 2005-05-03 · brand TARO-PHENYTOIN · ATC N03AB02 PHENYTOIN · form Suspension · route Oral · ingredients PHENYTOIN 125 MG/5ML · company Taro pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Taro-Phenytoin: Formulary list price $0.04 per unit (the source does not state the unit; exact figure $0.0444). What the ministry pays, not the patient.

Ministry pays: $0.0444 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02250896)

Source record
DIN 02250896: Taro-Phenytoin Raw flags: sec3=Y Item: 281200002; group id 439; item number 1098; lccId None; manufacturer id TAR Source form: O/L; strength: 25mg/mL Recorded listing: General benefit Source prices (unrounded): $0.0444; ministry $0.0444 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02250896 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73583
Interchangeable products
Dilantin-125 Suspension · DIN 00023450 · $0.0444
Shortage status: resolved shortage (ended September 4, 2025); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02250896
Shortage record checked October 6, 2026

Dilantin Infatabs · DIN 00023698 · 50 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
No interchangeable product listed in the Ontario extract
Dilantin Infatabs · DIN 00023698 Manufacturer: Upjohn Canada ULC; listing date 1996-10-01 Health Canada: Marketed since 2023-08-02 · brand DILANTIN INFATABS · ATC N03AB02 PHENYTOIN · form Tablet (chewable) · route Oral · ingredients PHENYTOIN 50 MG · company Bgp pharma ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Dilantin Infatabs: Formulary list price $0.11 per unit (the source does not state the unit; exact figure $0.1092). What the ministry pays, not the patient.

Ministry pays: $0.1092 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00023698)

Source record
DIN 00023698: Dilantin Infatabs Raw flags: sec3=Y Item: 281200001; group id 439; item number 1099; lccId None; manufacturer id UJC Source form: Tab; strength: 50mg Recorded listing: General benefit Source prices (unrounded): $0.1092; ministry $0.1092 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00023698 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1086
Shortage status: resolved shortage (ended June 5, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00023698
Shortage record checked October 6, 2026

Dilantin-30 Suspension · DIN 00023442 · 6 mg/mL · oral liquid

General benefit; Health Canada lists this DIN as Cancelled post market since 2025-12-09 — choose a marketed DIN from the same-category list.Discontinued December 9, 2025 · checked November 17, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-12-09 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-12-09 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
No interchangeable product listed in the Ontario extract
Dilantin-30 Suspension · DIN 00023442 Manufacturer: Upjohn Canada ULC; listing date 1996-10-01 Health Canada: Cancelled post market since 2025-12-09 · brand DILANTIN-30 SUSPENSION · ATC N03AB02 PHENYTOIN · form Suspension · route Oral · ingredients PHENYTOIN 30 MG/5ML · company Bgp pharma ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Dilantin-30 Suspension: Formulary list price $0.06 per unit (the source does not state the unit; exact figure $0.0588). What the ministry pays, not the patient.

Ministry pays: $0.0588 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00023442)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 00023442). DIN 00023442: Dilantin-30 Suspension Raw flags: dinStatus=E, sec3=Y Item: 281200003; group id 439; item number 1097; lccId None; manufacturer id UJC Source form: O/L; strength: 6mg/mL Recorded listing: General benefit; DIN status E, meaning unconfirmed Source prices (unrounded): $0.0588; ministry $0.0588 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00023442 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=769
Shortage status: discontinued (December 9, 2025, reported by BGP PHARMA ULC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00023442
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since December 9, 2025 — choose a marketed DIN from the same-category list.

Dilantin-125 Suspension · DIN 00023450 · 25 mg/mL · oral liquid

General benefit; Health Canada lists this DIN as Cancelled post market since 2025-12-09 — choose a marketed DIN from the same-category list.Discontinued December 9, 2025 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-12-09 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-12-09 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Dilantin-125 Suspension · DIN 00023450 Manufacturer: Upjohn Canada ULC; listing date 1996-10-01 Health Canada: Cancelled post market since 2025-12-09 · brand DILANTIN-125 SUSPENSION · ATC N03AB02 PHENYTOIN · form Suspension · route Oral · ingredients PHENYTOIN 125 MG/5ML · company Bgp pharma ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Ministry pays: $0.0444 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00023450)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 00023450). DIN 00023450: Dilantin-125 Suspension Raw flags: dinStatus=E, sec3=Y Item: 281200002; group id 439; item number 1098; lccId None; manufacturer id UJC Source form: O/L; strength: 25mg/mL Recorded listing: General benefit; DIN status E, meaning unconfirmed Source prices (unrounded): $0.0697; ministry $0.0444 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00023450 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=613
Interchangeable products
Taro-Phenytoin · DIN 02250896 · $0.0444
Shortage status: discontinued (December 9, 2025, reported by BGP PHARMA ULC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00023450
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since December 9, 2025 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (N03A): coverage varies; not interchangeable

  • Carbamazepine (Tegretol): general benefit, limited Use, not a benefit, listing status unconfirmed
  • Clonazepam (Rivotril): general benefit
  • Divalproex (Epival): general benefit
  • Ethosuximide (Zarontin): general benefit
  • Lamotrigine (Lamictal): general benefit
  • Primidone: general benefit, not a benefit

13 more in the class list below

Phenytoin (diphenylhydantoin) sodium

Form:

4 of 4 products shown

3 general benefit · 1 Limited Use

Dilantin · DIN 00022772 · 30 mg · capsule

General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
No interchangeable product listed in the Ontario extract
Dilantin · DIN 00022772 Manufacturer: Upjohn Canada ULC; listing date 1996-10-01 Health Canada: Marketed since 2023-06-07 · brand DILANTIN · ATC N03AB02 PHENYTOIN · form Capsule · route Oral · ingredients PHENYTOIN SODIUM 30 MG · company Bgp pharma ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Dilantin: Formulary list price $0.24 per unit (the source does not state the unit; exact figure $0.2369). What the ministry pays, not the patient.

Ministry pays: $0.2369 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00022772)

Source record
DIN 00022772: Dilantin Raw flags: sec3=Y Item: 281200005; group id 440; item number 1100; lccId None; manufacturer id UJC Source form: Cap; strength: 30mg Recorded listing: General benefit Source prices (unrounded): $0.2369; ministry $0.2369 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00022772 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1036
Shortage status: anticipated shortage (last updated September 29, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00022772
Shortage record checked October 6, 2026

Phenytoin Sodium Injection USP · DIN 00780626 · 50 mg/mL · injection solution (Preservative Free)

Limited Use, Reason for Use code 481, 657 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 481, 657 required
Write on scriptone applicable Reason for Use code, 481 or 657 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 481, 657
Reason for Use code 481 For the management of patients receiving palliative care*. Coverage limit: LU Authorization Period: 1 year Coverage limit: *The patient must have a progressive life-limiting illness and require this medication for palliative purposes. Reason for Use code 657 For the treatment of patients receiving care at home* who have failed or are unable to tolerate oral alternatives, and who require an injectable option to manage their condition. Coverage limit: LU Authorization Period: 1 year Coverage limit: *e.g., home care recipients, long-term care home residents.
No interchangeable product listed in the Ontario extract
Phenytoin Sodium Injection USP · DIN 00780626 Manufacturer: Sandoz Canada Inc.; listing date 2017-02-28 Health Canada: Marketed since 2005-10-01 · brand PHENYTOIN SODIUM INJECTION USP · ATC N03AB02 PHENYTOIN · form Liquid · route Intravenous, Intramuscular · ingredients PHENYTOIN SODIUM 50 MG/ML · company Sandoz canada incorporated · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Phenytoin Sodium Injection USP: Formulary list price $6.08 per unit (the source does not state the unit; exact figure $6.0785). What the ministry pays, not the patient.

Ministry pays: $6.0785 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00780626)

Source record
DIN 00780626: Phenytoin Sodium Injection USP Raw flags: sec12=Y, sec3=Y Item: 281200081; group id 441; item number 1102; lccId 00270; manufacturer id SDZ Source form: Inj Sol (Preservative Free); strength: 50mg/mL Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $6.0785; ministry $6.0785 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00780626 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9398
Shortage status: resolved shortage (ended March 27, 2023); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00780626
Shortage record checked October 6, 2026

Dilantin · DIN 00022780 · 100 mg · capsule

General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Dilantin · DIN 00022780 Manufacturer: Upjohn Canada ULC; listing date 1996-10-01 Health Canada: Marketed since 2023-06-07 · brand DILANTIN · ATC N03AB02 PHENYTOIN · form Capsule · route Oral · ingredients PHENYTOIN SODIUM 100 MG · company Bgp pharma ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Ministry pays: $0.0665 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00022780)

Source record
DIN 00022780: Dilantin Raw flags: sec3=Y Item: 281200004; group id 440; item number 1101; lccId None; manufacturer id UJC Source form: Cap; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.1247; ministry $0.0665 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00022780 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1037
Interchangeable products
Phenytoin Sodium · DIN 02460912 · $0.0665
Shortage status: resolved shortage (ended April 21, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00022780
Shortage record checked October 6, 2026

Phenytoin Sodium · DIN 02460912 · 100 mg · capsule

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Phenytoin Sodium · DIN 02460912 Manufacturer: A A Pharma Inc.; listing date 2017-09-28 Health Canada: Marketed since 2021-07-13 · brand PHENYTOIN SODIUM · ATC N03AB02 PHENYTOIN · form Capsule · route Oral · ingredients PHENYTOIN SODIUM 100 MG · company Aa pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Phenytoin Sodium: Formulary list price $0.07 per unit (the source does not state the unit; exact figure $0.0665). What the ministry pays, not the patient.

Ministry pays: $0.0665 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02460912)

Source record
DIN 02460912: Phenytoin Sodium Raw flags: sec3=Y Item: 281200004; group id 440; item number 1101; lccId None; manufacturer id AAP Source form: Cap; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.0665; ministry $0.0665 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02460912 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94843
Interchangeable products
Dilantin · DIN 00022780 · $0.0665
Shortage status: resolved shortage (ended May 15, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02460912
Shortage record checked October 6, 2026

Other products in the same Health Canada class (N03A): coverage varies; not interchangeable

  • Carbamazepine (Tegretol): general benefit, limited Use, not a benefit, listing status unconfirmed
  • Clonazepam (Rivotril): general benefit
  • Divalproex (Epival): general benefit
  • Ethosuximide (Zarontin): general benefit
  • Lamotrigine (Lamictal): general benefit
  • Primidone: general benefit, not a benefit

13 more in the class list below

Other drugs in the same formulary class (28:12 Anticonvulsants) and how they are covered

Matched class: 28:12 Anticonvulsants

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: CLONAZEPAM, DIVALPROEX SODIUM, ETHOSUXIMIDE, VALPROATE SODIUM Some products covered without a code (check the product listing): CARBAMAZEPINE, GABAPENTIN, LAMOTRIGINE, PREGABALIN, PRIMIDONE, TOPIRAMATE, VALPROIC ACID 28:12 Anticonvulsants

CARBAMAZEPINE

· 15 products · Listed, not a benefit (3), General benefit (6), Temporary benefit (2), Limited Use, codes 67 (4) · strengths: 100mg, 200mg, 400mg, 100mg/5mL · Chew Tab, ER Tab, LA Tab, Oral Susp, Tab

CLONAZEPAM

· 9 products · General benefit · strengths: 0.5mg, 2mg · Tab

DIVALPROEX SODIUM

· 9 products · General benefit · strengths: 125mg, 250mg, 500mg · Ent Tab

ETHOSUXIMIDE

· 4 products · General benefit · strengths: 250mg, 50mg/mL · Cap, O/L

LAMOTRIGINE

· 28 products · General benefit (25), General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (3) · strengths: 25mg, 100mg, 150mg · Tab

PRIMIDONE

· 4 products · General benefit (2), Listed, not a benefit (2) · strengths: 125mg, 250mg · Tab

TOPIRAMATE

· 54 products · Limited Use, codes 321 (2), Off-Formulary Interchangeable, not an ODB benefit (3), General benefit (49) · strengths: 15mg, 25mg, 50mg, 100mg, 200mg · Sprinkle Cap, Tab

VALPROATE SODIUM

· 5 products · General benefit · strengths: 50mg/mL · O/L

VALPROIC ACID

· 5 products · Listed, not a benefit (2), General benefit (3) · strengths: 250mg, 500mg · Cap, Ent Cap

BRIVARACETAM

· 12 products · Limited Use, codes 548 · strengths: 10mg, 25mg, 50mg, 75mg, 100mg · Tab

CENOBAMATE

· 9 products · Limited Use, codes 719 · strengths: 12.5mg, 25mg, 50mg, 100mg, 150mg, 200mg, 12.5mg & 25mg, 50mg & 100mg, 150mg & 200mg · Tab, Tab - (Starter Kit)

ESLICARBAZEPINE ACETATE

· 12 products · Limited Use, codes 430 · strengths: 200mg, 400mg, 600mg, 800mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 28:12 and 10 more
Full class listing Related classes: 28:08 Analgesics, 28:10 Opiate Antagonists, 28:16 Psychotherapeutic Agents, 28:20 C.N.S. Stimulants, 28:24 Sedatives and Hypnotics, 28:36 Antiparkinsonian Agents, 28:92 Miscellaneous Central Nervous System Drugs Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS DILANTIN INFATABS (phenytoin chewable tablets), DILANTIN-30 SUSPENSION and DILANTIN- 125 SUSPENSION (phenytoin oral suspensions) are indicated for: • the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures. Phenytoin is not effective for absence (petit mal) seizures, and not indicated for seizures due to hypoglycemic or other metabolic causes. 1.1 Pediatrics Pediatrics (< 18 years of age): See 4.2 Recommended Dose and Dosage Adjustments, Pediatrics. 1.2 Geriatrics Evidence from clinical studies and experience suggests that use in the geriatric population is associated with differences in safety or effectiveness. See 4.2 Recommended Dose and Dosage Adjustments, Geriatrics. https://pdf.hres.ca/dpd_pm/00071910.PDF PM date: August 2, 2023 Source product: DILANTIN INFATABS; DIN 00023698; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.
What the Health Canada label says it is for
1 INDICATIONS DILANTIN (extended phenytoin sodium capsules) are indicated for:  the control of generalized tonic-clonic and psychomotor (grand mal and temporal lobe) seizures; and  the prevention and treatment of seizures occurring during or following neurosurgery. Phenytoin is not effective for absence (petit mal) seizures, and not indicated for seizures due to hypoglycemic or other metabolic causes. 1.1 Pediatrics Pediatrics (< 18 years of age): See 4.2 Recommended Dose and Dosage Adjustments, Pediatrics. 1.2 Geriatrics Evidence from clinical studies and experience suggests that use in the geriatric population is associated with differences in safety or effectiveness. See 4.2 Recommended Dose and Dosage Adjustments, Geriatrics. https://pdf.hres.ca/dpd_pm/00071169.PDF PM date: JUN 07, 2023 Source product: DILANTIN; DIN 00022772; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Dilantin-30 Suspension · DIN 00023442 Shortage status: discontinued (2025-12-09, reported by BGP PHARMA ULC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00023442

Check this DIN again

Dilantin-125 Suspension · DIN 00023450 Shortage status: discontinued (2025-12-09, reported by BGP PHARMA ULC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00023450

Check this DIN again